MindFrame, Inc. Completes $75 Million Sale to Covidien
Represented MindFrame, Inc. in its acquisition by Covidien for $75 million.
The acquisition of MindFrame broadens the Company’s product offerings for the treatment of acute ischemic stroke."
Represented MindFrame, Inc. in its acquisition by Covidien for $75 million.
The acquisition of MindFrame broadens the Company’s product offerings for the treatment of acute ischemic stroke."